Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of September 8-14, 2023.

He begins by highlighting the AACR Cancer Progress Reports which are centred around recent developments of cancer research and identifying priority efforts for future efforts.

Dr Morgan details a Lancet paper on the promising combination of FOLFOX plus regorafenib and nivolumab for advanced EG cancer.

He also highlights noteworthy studies in triple-negative breast cancer, prostate cancer, non-small cell lung cancer and head and neck squamous cell carcinoma.

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer